Siren »

Arrivent Biopharma shares owned by Siren

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Siren from 13F filings

Historical chart of Siren investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Siren

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 700k 18.45
2025-06-30 $15M 700k 21.77

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Disc Medicine (IRON)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Avidity Biosciences Ord (RNA)
Stoke Therapeutics (STOK)
Lexicon Pharmaceuticals Com New (LXRX)
Rhythm Pharmaceuticals (RYTM)

View all positions for Siren

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma